Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapy
- 1 December 2016
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 383 (1) , 41-52
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stressNucleic Acids Research, 2012
- RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastomaProceedings of the National Academy of Sciences, 2011
- Chk1 inhibits replication factory activation but allows dormant origin firing in existing factoriesJournal of Cell Biology, 2010
- Chk1 promotes replication fork progression by controlling replication initiationProceedings of the National Academy of Sciences, 2010
- New Insights into Checkpoint Kinase 1 in the DNA Damage Response Signaling NetworkClinical Cancer Research, 2010
- Claspin Promotes Normal Replication Fork Rates in Human CellsMolecular Biology of the Cell, 2008
- Chk1 and Claspin potentiate PCNA ubiquitinationGenes & Development, 2008
- Chk1 regulates the density of active replication origins during the vertebrate S phaseThe EMBO Journal, 2007
- Specific Role of Chk1 Phosphorylations in Cell Survival and Checkpoint ActivationMolecular and Cellular Biology, 2007
- ATM and ATR promote Mre11 dependent restart of collapsed replication forks and prevent accumulation of DNA breaksThe EMBO Journal, 2006